Literature DB >> 23589998

Stage IB1 cervical cancer patients with an MRI-measured tumor size < or = 2 cm might be candidates for less-radical surgery.

J Kodama1, C Fukushima, T Kusumoto, K Nakamura, N Seki, A Hongo, Y Hiramatsu.   

Abstract

OBJECTIVES: To examine the correlation between histopathology and magnetic resonance imaging (MRI) measured tumor size and define whether patients with Stage IB1 cervical cancer with an MRI-measured tumor size < or = 2 cm can be candidates for less-radical surgery.
MATERIALS AND METHODS: The authors retrospectively reviewed 200 patients with Stage IB1 cervical cancer who underwent radical hysterectomy (class III) and pelvic lymphadenectomy. The largest diameter of the tumor was determined by MRI in 52 consecutive cases.
RESULTS: Regarding risk factors for parametrial involvement, only tumor size and age are known before definitive surgery without conization. Multivariate analysis of these risk factors revealed that both tumor size and old age were independently associated with parametrial involvement. Eighty-eight patients had a tumor size < or = 2 cm and an age < or = 50 years, two of which (2.3%) had parametrial involvement. In 52 consecutive patients, a significant correlation between histopathology- and MRI-measured tumor size was found (r = 0.787). Twenty-three patients had an MRI-measured tumor size < or = 2 cm, none of which had parametrial involvement.
CONCLUSIONS: Patients with Stage IB1 cervical cancer lesions with a tumor size < or = 2 cm measured by MRI and age < or = 50 years can be treated with less-radical surgery.

Entities:  

Mesh:

Year:  2013        PMID: 23589998

Source DB:  PubMed          Journal:  Eur J Gynaecol Oncol        ISSN: 0392-2936            Impact factor:   0.196


  6 in total

Review 1.  [The 2019 FIGO classification for cervical carcinoma-what's new?]

Authors:  L-C Horn; C E Brambs; S Opitz; U A Ulrich; A K Höhn
Journal:  Pathologe       Date:  2019-11       Impact factor: 1.011

2.  [Cervical cancer : Update on morphology].

Authors:  L-C Horn; C E Brambs; R Handzel; S Lax; I Sändig; D Schmidt; K Schierle
Journal:  Pathologe       Date:  2016-11       Impact factor: 1.011

3.  What MRI-based tumor size measurement is best for predicting long-term survival in uterine cervical cancer?

Authors:  Njål Lura; Kari S Wagner-Larsen; David Forsse; Jone Trovik; Mari K Halle; Bjørn I Bertelsen; Øyvind Salvesen; Kathrine Woie; Camilla Krakstad; Ingfrid S Haldorsen
Journal:  Insights Imaging       Date:  2022-06-17

4.  Pretreatment risk factors for parametrial involvement in FIGO stage IB1 cervical cancer.

Authors:  Hiroyuki Yamazaki; Yukiharu Todo; Kazuhira Okamoto; Katsushige Yamashiro; Hidenori Kato
Journal:  J Gynecol Oncol       Date:  2015-07-14       Impact factor: 4.401

5.  Utility of 3T MRI in Women with IB1 Cervical Cancer in Determining the Necessity of Less Invasive Surgery.

Authors:  Soo Young Jeong; Byung Kwan Park; Chel Hun Choi; Yoo-Young Lee; Tae-Joong Kim; Jeong-Won Lee; Byoungi-Gie Kim
Journal:  Cancers (Basel)       Date:  2022-01-04       Impact factor: 6.639

6.  The Relationship Between Parametrial Involvement and Parametrial Tissue Removed in Radical Surgery in Early-Stage Cervical Cancer.

Authors:  Ozer Birge; Mehmet Sait Bakir; Selen Dogan; Hasan Aykut Tuncer; Tayup Simsek
Journal:  World J Oncol       Date:  2022-04-23
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.